LAB 425: Acquisition
Filed with the SEC on · accession 0001140361-26-044935
LAB filed a 425 (425) with the SEC on Nov 19, 2026. Standard BioTools stockholders approved all proposals related to its merger with Treeline Biosciences, including share issuance, a reverse stock split, and a post-closing equity incentive plan. The stock moved +7.7% by the first close after the filing.
Summary of the filing
Standard BioTools stockholders approved all proposals related to its merger with Treeline Biosciences, including share issuance, a reverse stock split, and a post-closing equity incentive plan. The company will also divest its Element Mass Cytometry business and rename itself Treeline Biosciences, Inc.
Key details
How LAB stock reacted
Close before
$0.57
Nov 18, 2026
First close after
+7.67%
$0.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for LAB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LAB?
Click hereFrequently asked questions
What did LAB file with the SEC on Nov 19, 2026?
LAB filed a 425 (Acquisition). Standard BioTools stockholders approved all proposals related to its merger with Treeline Biosciences, including share issuance, a reverse stock split, and a post-closing equity incentive plan. The company will also divest its Element Mass Cytometry business and rename itself Treeline Biosciences, Inc.
What does a acquisition mean for LAB stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 425?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 425 (425): A report the company filed with the SEC (the US market regulator).
How did LAB stock react to this filing?
LAB closed at $0.57 before the filing and $0.61 on Nov 19, 2026 (+7.67%).
Other LAB SEC filings
- 8-K · Stock splitNov 19, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 8-K · Legal settlementNov 16, 2026
- 8-K · DivestitureNov 3, 2026
- 10-Q · SEC filingNov 3, 2026
- 424B3 · AcquisitionOct 30, 2026
- 424B3 · AcquisitionOct 21, 2026
- EFFECT · Shelf registrationOct 21, 2026
- S-4 · SEC filingOct 21, 2026
- S-4 · SEC filingOct 9, 2026
Get alerts when LAB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days